[Therapy of psoriasis using dehydroepiandrosterone-sulfate].
D000284:Administration, Oral; D000737:Androstenols / Q000097:blood / Q000652:urine; D003687:Dehydroepiandrosterone / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use* / Q000652:urine; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D005952:Glucose-6-Phosphatase / Q000097:blood / Q000494:pharmacology; D006801:Humans; D008297:Male; D010428:Pentosephosphates / Q000378:metabolism; D011379:Prognosis; D011565:Psoriasis / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism
D000737:Androstenols; D010428:Pentosephosphates; D003687:Dehydroepiandrosterone; D005952:Glucose-6-Phosphatase
Zur Therapie der Psoriasis mit Dehydroepiandrosteron-Sulfat.